QOL Efficacy of Adapted Physical Activity for Patients With Fibromyalgia

NCT03640806 | Completed

• 1 other identifier: 2017-57
• Study Type: interventional
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

Fibromyalgia affects at least 4% of the population. This chronic painful pathology is a source of social exclusion with a major impact on professional activity; To our knowledge, no study has demonstrated with sufficient evidence the effectiveness of the practice of well-defined adapted physical activity (APA) via a reproducible program of physical activity that has been the mechanisms of action that underlie this efficacy by biology and functional brain imaging (PET CT) in this context. In addition, the publications mention recruitment difficulties, a high drop-out rate and a difficult maintenance of the benefits of physical activity in the long term, or even a return to the initial level after a few months. The programs evaluated do not seem to take into account the peculiarities of patients, their coping coping strategies, associated with chronic pain and disability . In order to reinforce the durability of the benefits of our intervention, we make modulating factors of "coping" styles of therapeutic targets in their own right, as well as muscular strength, aerobic capacity or flexibility. Thus, cognitive-behavioral therapy (CBT) procedures validated in the treatment of chronic pain are adapted and transposed to our APA program in order to propose specific strategies. "Fibromy'activ" aims to act upstream and downstream of the formation of health inequalities found in the population suffering from fibromyalgia and favored by the natural evolution of the disease: These workshops tend to favorably influence the course of life and to define a reproducible interdisciplinary protocol. It is a question of making accessible and reproducible the practice of adapted physical activity (APA), non-medicinal therapeutic recommended by the HAS since 2010 , by the EULAR in 2016, but not refunded, poorly protocolized therefore not reproducible and little implementation. It is part of the spirit of the amended Health Act with the coming into force of the application decree since March 2017 "Physical Prescription".

Conditions

Fibromyalgia

Outcome Measures

Primary Outcomes (1)

• The Fibromyalgia Impact Questionnaire

  FIQ Questionnaire was developed in 1991 as a specific measuring instrument for assessing the health status of patients with fibromyalgia. The validation of this adaptation and the evaluation of its psychometric properties were carried out by Perrot in 2002. self-administered, exploring ten dimensions of the impact of pathology on quality of life. Scale from 0 to 10, a high figure corresponding to a greater disadvantage or handicap. The analysis of the evolution of the FIQ over time, spontaneously or under treatment, is therefore dimension by dimension, in order to maintain a clinical informative value, as well as by an aggregate score ( corresponding to the algebraic sum of the dimensions evaluated, compared to 100 units). A weighting of the aggregate score is expected when the patient can not assess impact on professional activity.

  1 hour

Study Arms (2)

PHYSICAL ACTIVITY

EXPERIMENTAL

Standard support for 12 months (HAS 2010, EULAR 2016) 3 fibromyactiv workshops per week during the first 6 months, or 72 sessions. Each workshop lasts 2 hours of physical activity.

Other: PHYSICAL ACTIVITY

CONTROL

NO INTERVENTION

Standard care for 12 months (HAS 2010, EULAR 2016) with Pain Consultation every 3 months.

Interventions

PHYSICAL ACTIVITY OTHER

3 fibromyactiv workshops per week during the first 6 months, or 72 sessions. Each workshop lasts 2 hours of physical activity.

PHYSICAL ACTIVITY

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Female or male subject, 18 years of age or older, not pregnant, not breastfeeding, not deprived of liberty;
• Subject with fibromyalgia meeting the criteria of the American College of Rheumatology (ACR)
• Subject managed by the Center for Assessment and Pain Management of CHU Timone or addressed to it in consultation / day hospital;
• Subject free from any general illness or serious psychiatric disorders, and any infectious, inflammatory, tumoral, vascular, degenerative or traumatic pathology of the central nervous system, determined during the interrogation;
• Subject not having a history of alcoholism or drug addiction,
• Subject with no contraindication to PET scintigraphy (pregnancy and lactation),
• Subject with no indication of physical activity;
• Subject whose general state and comprehension of French makes it possible to complete a questionnaire;
• Topic with average pain\> 4/10 at EN
• Subject affiliated with Social Security
• Subject who has read, understood and signed informed consent after informing and accepting protocol rules

You may not qualify if:

• Major subject under legal protection or unable to express their consent: L1121-8 of the CSP
• Subject presenting a contraindication to the practice of physical activity, to scintigraphic scanning by PET,
• Subject deprived of liberty following a judicial or administrative decision
• Subject with psychiatric illness or Personality Disorder making group work difficult
• Subject refusing to participate in the study or not signing the consent

Sponsors & Collaborators

• Assistance Publique Hopitaux De Marseille: lead

Study Sites (1)

Assistance Publique Des Hopitaux de Marseille

Marseille, PACA, 13354, France

Location

MeSH Terms

Conditions

Fibromyalgia

Interventions

Exercise

Condition Hierarchy (Ancestors)

Muscular Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Neuromuscular Diseases; Nervous System Diseases

Intervention Hierarchy (Ancestors)

Motor Activity; Movement; Musculoskeletal Physiological Phenomena; Musculoskeletal and Neural Physiological Phenomena

Study Officials

• EMILIE GARRIDO PRADALIE

  APHM

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 17, 2018
• First Posted: August 21, 2018
• Study Start: November 15, 2018
• Primary Completion: June 30, 2020
• Study Completion: August 10, 2020
• Last Updated: August 14, 2020

Record last verified: 2020-08

Locations

FR (1)